Evidence that Farnesyltransferase Inhibitors Suppress Ras Transformation by Interfering with Rho Activity

REFERENCES

• Adamson, P., C. J. Marshall, A. Hall, and P. A. Tilbrook. 1992. Posttrans-lational modification of p21rho proteins. J. Biol. Chem. 267:20033–20038.
   PubMed Web of Science ®Google Scholar
• Adamson, P., H. F. Paterson, and A. Hall. 1992. Intracellular localization of the p21rho proteins. J. Cell Biol. 119:617–627.
   PubMed Web of Science ®Google Scholar
• Armstrong, S. A., V. C. Hannah, J. L. Goldstein, and M. S. Brown. 1995. CAAX geranylgeranyl transferase (GGTase-1) transfers farnesyl as effi-ciently as geranylgeranyl to RhoB. J. Biol. Chem. 270:7864–7868.
   PubMed Web of Science ®Google Scholar
• Bar-Sagi, D., and J. R. Feramisco. 1986. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science 233: 1061–1066.
   PubMed Web of Science ®Google Scholar
• Brown, M. S., and J. L. Goldstein. 1993. Protein prenylation: mad bet for Rab. Nature (London) 366:14–15.
   PubMedGoogle Scholar
• Burridge, K., K. Fath, T. Kelly, G. Nuckolls, and C. Turner. 1988. Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton. Annu. Rev. Cell Biol. 7:337–374.
   Google Scholar
• Buss, J. E., P. A. Solski, J. P. Schaeffer, M. J. MacDonald, and C. J. Der. 1989. Activation of the cellular proto-oncogene product p21Ras by addition of a myristylation signal. Science 243:1600–1603.
   PubMed Web of Science ®Google Scholar
• Casey, P. J., P. A. Soski, C. J. Der, and J. E. Buss. 1989. p21ras is modified by a farnesyl isoprenoid. Proc. Natl. Acad. Sci. USA 86:8232–8237.
   PubMedGoogle Scholar
• Chen, C., and H. Okayama. 1987. High efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745–2752.
   PubMed Web of Science ®Google Scholar
• Clarke, S. 1992. Protein isoprenylation and methylation at carboxyl-terminal cysteine residues. Annu. Rev. Biochem. 61:355–386.
   PubMed Web of Science ®Google Scholar
• Cox, A. D., and C. J. Der. 1994. Biological assays for cellular transformation. Methods Enzymol. 238:277–294.
   PubMedGoogle Scholar
• Cox, A. D., A. M. Garcia, J. K. Westwick, J. J. Kowalczyk, M. D. Lewis, D. A. Brenner, and C. J. Der. 1995. The CAAX peptidomimetic compound B581 specifically blocks farnesylated, but not geranylgeranylated or myristylated, oncogenic Ras signaling and transformation. J. Biol. Chem. 269: 19203–19206.
   Google Scholar
• Dartsch, P. C., M. Ritter, D. Häussinger, and F. Lang. 1994. Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene. Eur. J. Cell Biol. 63:316–325.
   PubMedGoogle Scholar
• DeClue, J. E., W. C. Vass, A. G. Papageorge, D. R. Lowy, and B. M. Williams. 1991. Inhibition of cell growth by lovastatin is independent of ras function. Cancer Res. 51:712–717.
   PubMed Web of Science ®Google Scholar
• Farnsworth, C. C., S. L. Wolda, M. H. Gelb, and J. A. Glomset. 1989. Human lamin B contains a farnesylated cysteine residue. J. Biol. Chem. 264:20422–20429.
   PubMed Web of Science ®Google Scholar
• Garcia, A. M., C. Rowell, K. Ackermann, J. J. Kowalczyk, and M. D. Lewis. 1993. Peptidomimetic inhibitors of Ras farnesylation and function in whole cells. J. Biol. Chem. 268:18415–18418.
   PubMed Web of Science ®Google Scholar
• Gibbs, J., A. Oliff, and N. E. Kohl. 1994. Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic. Cell 77:175–178.
   PubMed Web of Science ®Google Scholar
• Gibbs, J. B. 1991. Ras C-terminal processing enzymes—new drug targets? Cell 65:1–4.
   PubMed Web of Science ®Google Scholar
• Glomset, J. A., M. H. Gelb, and C. C. Farnsworth. 1990. Prenyl proteins in eucaryotic cells: a new type of membrane anchor. Trends Biochem. Sci. 15:139–142.
   PubMed Web of Science ®Google Scholar
• Hall, A. 1992. Ras-related GTPases and the cytoskeleton. Mol. Biol. Cell 3:475–479.
   PubMed Web of Science ®Google Scholar
• Hancock, J. F., H. Paterson, and C. J. Marshall. 1990. A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane. Cell 63:133–139.
   PubMed Web of Science ®Google Scholar
• Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Ingber, D. E., L. Dike, L. Hansen, S. Karp, H. Liley, A. Maniotis, H. McNamee, D. Mooney, G. Plopper, J. Sims, and N. Wang. 1994. Cellular tensegrity: exploring how mechanical changes in the cytoskeleton regulate cell growth, migration, and tissue pattern during morphogenesis. Int. Rev. Cytol. 150:173–224.
   PubMed Web of Science ®Google Scholar
• Jahner, D., and T. Hunter. 1991. The ras-related gene rhoB is an immediate-early gene inducible by v-Fps, epidermal growth factor, and platelet-derived growth factor in rat fibroblasts. Mol. Cell. Biol. 11:3682–3690.
   PubMed Web of Science ®Google Scholar
• James, G. L., J. L. Goldstein, M. S. Brown, T. E. Rawson, T. C. Somers, R. S. McDowell, C. W. Crowley, B. K. Lucas, A. D. Levinson, and J. C. Marsters. 1993. Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells. Science 260:1937–1942.
   PubMed Web of Science ®Google Scholar
• Katayama, M., M. Kawata, Y. Yoshida, H. Horiuchi, T. Yamamoto, Y. Matsuura, and Y. Takai. 1991. The posttranslationally modified C-terminal structure of bovine aortic smooth muscle rhoA p21. J. Biol. Chem. 266: 12639–12645.
   PubMed Web of Science ®Google Scholar
• Kato, K., A. D. Cox, M. M. Hisaka, S. M. Graham, J. E. Buss, and C. J. Der. 1992. Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity. Proc. Natl. Acad. Sci. USA 89:6403–6407.
   PubMed Web of Science ®Google Scholar
• Khosravi-Far, R., P. A. Solski, G. J. Clark., M. S. Kinch, and C. J. Der. 1995. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol. Cell. Biol. 15:6443–6453.
   PubMed Web of Science ®Google Scholar
• Kohl, N. E., S. D. Mosser, S. J. deSolms, E. A. Giuliani, D. L. Pompliano, S. L. Graham, R. L. Smith, E. M. Scolnick, A. Oliff, and J. B. Gibbs. 1993. Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science 260:1934–1937.
   PubMed Web of Science ®Google Scholar
• Kohl, N. E., C. A. Omer, M. W. Conner, N. J. Anthony, J. P. Davide, S. J. deSolms, E. A. Guiliani, R. P. Gomez, S. L. Graham, K. Hamilton, L. K. Handt, G. D. Hartman, K. S. Koblan, A. M. Kral, P. J. Miller, S. D. Mosser, T. J. O'Neill, E. Rands, M. D. Schaber, J. B. Gibbs, and A. Oliff. 1995. Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice. Nature Med. 1:792–797.
   PubMed Web of Science ®Google Scholar
• Kohl, N. E., F. Redner, S. Mosser, E. A. Guiliani, S. J. deSolms, M. W. Conner, N. J. Anthony, W. J. Holtz, R. P. Gomez, T.-J. Lee, R. L. Smith, S. L. Graham, G. D. Hartman, J. Gibbs, and A. Oliff. 1994. Protein farnesyltrans-ferase inhibitors block the growth of ras-dependent tumors in nude mice. Proc. Natl. Acad. Sci. USA 91:9141–9145.
   PubMed Web of Science ®Google Scholar
• Lacal, P. M., C. Y. Pennington, and J. C. Lacal. 1988. Transforming activity of ras proteins translocated to the plasma membrane by a myristoylation sequence from the src gene product. Oncogene 2:533–537.
   PubMedGoogle Scholar
• Lebowitz, P. Unpublished data.
   Google Scholar
• Lo, S. H., and L. B. Chen. 1994. Focal adhesion as a signal transduction organelle. Cancer Metastasis Rev. 13:9–24.
   PubMed Web of Science ®Google Scholar
• Maltese, W. A. 1990. Posttranslational modification of proteins by isopre-noids in mammalian cells. FASEB J. 4:3319–3327.
   PubMed Web of Science ®Google Scholar
• Manne, V., N. Yan, J. M. Carboni, A. V. Tuomari, C. S. Ricca, J. G. Brown, M. L. Andahazy, R. J. Schmidt, D. Patel, R. Zahler, R. Weinmann, C. J. Der, A. D. Cox, J. T. Hunt, E. M. Gordon, M. Barbacid, and B. R. Seizinger. 1995. Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells. Oncogene 10:1763–1779.
   PubMed Web of Science ®Google Scholar
• Marshall, C. J. 1993. Protein prenylation: a mediator of protein-protein interactions. Science 259:1865–1866.
   PubMed Web of Science ®Google Scholar
• Moores, S. L., M. D. Schaber, S. D. Mosser, E. Rands, M. B. O'Hara, V. M. Garsky, M. S. Marshall, D. L. Pompliano, and J. B. Gibbs. 1991. Sequence dependence of protein isoprenylation. J. Biol. Chem. 266:14603–14610.
   PubMed Web of Science ®Google Scholar
• Newman, C. M., and A. I. Magee. 1993. Posttranslational processing of the ras superfamily of small GTP-binding proteins. Biochim. Biophys. Acta 1155: 79–96.
   PubMedGoogle Scholar
• Niman, H. L., R. A. Houghten, L. E. Walker, R. A. Reisfeld, I. A. Wilson, J. M. Hogle, and R. A. Lerner. 1983. Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. Proc. Natl. Acad. Sci. USA 80:4949–4953.
   PubMed Web of Science ®Google Scholar
• Paterson, H. F., A. J. Self, M. D. Garrett, I. Just, K. Aktories, and A. Hall. 1990. Microinjection of recombinant p21rho induces rapid changes in cell morphology. J. Cell Biol. 111:1001–1007.
   PubMed Web of Science ®Google Scholar
• Pompliano, D. L., E. Rands, M. D. Schaber, S. D. Mosser, N. J. Anthony, and J. B. Gibbs. 1992. Steady-state kinetic mechanism of Ras farnesyl:protein transferase. Biochemistry 31:3800–3807.
   PubMed Web of Science ®Google Scholar
• Prendergast, G. C., J. P. Davide, S. J. deSolms, E. Giuliani, S. Graham, J. B. Gibbs, A. Oliff, and N. E. Kohl. 1994. Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton. Mol. Cell. Biol. 14:4193–4202.
   PubMed Web of Science ®Google Scholar
• Prendergast, G. C., J. P. Davide, A. Kral, R. D. Diehl, C. A. Omer, J. B. Gibbs, and N. E. Kohl. 1993. Negative growth selection against rodent fibroblasts targeted for genetic inhibition of farnesyl transferase. Cell Growth Differ. 4:707–713.
   PubMedGoogle Scholar
• Prendergast, G. C., L. E. Diamond, D. Dahl, and M. D. Cole. 1990. The c-myc-regulated gene mr1 encodes plasminogen activator inhibitor-1. Mol. Cell. Biol. 10:1265–1269.
   PubMed Web of Science ®Google Scholar
• Prendergast, G. C., R. Khosravi-Far, P. Solski, H. Kurzawa, P. Lebowitz, and C. J. Der. 1995. Critical role of Rho in cell transformation by oncogenic Ras. Oncogene 10:2289–2296.
   PubMed Web of Science ®Google Scholar
• Prendergast, G. C., and E. B. Ziff. 1991. Mbh1: a novel gelsolin/severin-related protein which binds actin in vitro and exhibits nuclear localization in vivo. EMBO J. 10:757–766.
   PubMed Web of Science ®Google Scholar
• Qiu, R. G., J. Chen, D. Kirn, F. McCormick, and M. Symons. 1995. An essential role for Rac in Ras transformation. Nature (London) 374:457–459.
   PubMed Web of Science ®Google Scholar
• Ridley, A. J. 1994. Membrane ruffling and signal transduction. BioEssays 16:321–327.
   PubMed Web of Science ®Google Scholar
• Ridley, A. J., and A. Hall. 1992. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70:389–399.
   PubMed Web of Science ®Google Scholar
• Ridley, A. J., H. F. Paterson, C. L. Johnston, D. Diekmann, and A. Hall. 1992. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70:401–410.
   PubMed Web of Science ®Google Scholar
• Schafer, W. R., and J. Rine. 1992. Protein prenylation: genes, enzymes, targets, and functions. Annu. Rev. Genet. 26:209–237.
   PubMed Web of Science ®Google Scholar
• Schlaepfer, D. D., S. K. Hanks, T. Hunter, and P. van der Geer. 1994. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature (London) 372:786–791.
   PubMed Web of Science ®Google Scholar
• Ulsh, L. S., and T. Y. Shih. 1984. Metabolic turnover of human c-rasH p21 protein of EJ bladder carcinoma and its normal cellular and viral homologs. Mol. Cell. Biol. 4:1647–1652.
   PubMedGoogle Scholar
• Wyss, A., S. Kaech, and H. K. Ballmer. 1990. Myristylation of pp60c-src is not required for complex formation with polyomavirus middle-T antigen. J. Virol. 64:5163–5166.
   PubMedGoogle Scholar
• Yamamoto, M., N. Marui, T. Sakai, N. Morii, S. Kozaki, K. Ikai, S. Imamura, and S. Narumiya. 1993. ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle. Oncogene 8:1449–1455.
   PubMed Web of Science ®Google Scholar
• Yeramian, P., P. Chardin, P. Madaule, and A. Tavitian. 1987. Nucleotide sequence of human rho cDNA clone 12. Nucleic Acids Res. 15:1869.
   PubMed Web of Science ®Google Scholar